
Core Laboratories Inc. (NYSE:CLB – Free Report) – Research analysts at Zacks Research increased their Q4 2027 earnings per share estimates for shares of Core Laboratories in a research note issued on Wednesday, November 18th. Zacks Research analyst Team now expects that the oil and gas company will post earnings per share of $0.23 for the quarter, up from their prior estimate of $0.22. The consensus estimate for Core Laboratories’ current full-year earnings is $0.56 per share. Zacks Research also issued estimates for Core Laboratories’ Q1 2028 earnings at $0.26 EPS and Q2 2028 earnings at $0.32 EPS.
Core Laboratories (NYSE:CLB – Get Free Report) last issued its quarterly earnings data on Wednesday, October 28th. The oil and gas company reported $0.16 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.16. Core Laboratories had a net margin of 3.42% and a return on equity of 8.94%. The business had revenue of $132.08 million during the quarter, compared to analysts’ expectations of $131.87 million. During the same period in the previous year, the company earned $0.22 earnings per share. Core Laboratories’s revenue for the quarter was down 1.8% on a year-over-year basis.
Get Our Latest Analysis on Core Laboratories
Core Laboratories Trading Down 7.8%
Shares of CLB stock opened at $7.75 on Friday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.60 and a current ratio of 2.19. The firm has a fifty day moving average of $9.95 and a 200-day moving average of $13.14. The stock has a market cap of $354.88 million, a price-to-earnings ratio of 20.38, a P/E/G ratio of 1.56 and a beta of 1.18. Core Laboratories has a 52-week low of $7.71 and a 52-week high of $20.36.
Core Laboratories Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Monday, November 9th will be given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Monday, November 9th. Core Laboratories’s payout ratio is 10.53%.
Institutional Investors Weigh In On Core Laboratories
Hedge funds have recently bought and sold shares of the stock. State of Wyoming boosted its position in shares of Core Laboratories by 267.7% in the first quarter. State of Wyoming now owns 4,626 shares of the oil and gas company’s stock valued at $78,000 after acquiring an additional 3,368 shares during the period. Voya Investment Management LLC acquired a new position in Core Laboratories in the 3rd quarter valued at $98,000. Corient Private Wealth LP acquired a new position in Core Laboratories in the second quarter valued at about $141,000. The Manufacturers Life Insurance Company bought a new stake in shares of Core Laboratories during the 2nd quarter worth approximately $156,000. Finally, Fifth Third Bancorp boosted its holdings in shares of Core Laboratories by 2,397.6% in the 1st quarter. Fifth Third Bancorp now owns 11,414 shares of the oil and gas company’s stock valued at $192,000 after purchasing an additional 10,957 shares in the last quarter. 97.81% of the stock is currently owned by institutional investors and hedge funds.
About Core Laboratories
Core Laboratories Inc. provides specialized services and products to the oil and natural gas industry. Its work helps customers evaluate reservoirs and improve the performance of producing wells. The company’s Reservoir Description business analyzes rock and fluid samples and provides laboratory testing, data, and reservoir studies. These services help energy companies assess subsurface properties and make decisions about exploration and field development. Through its Production Enhancement business, Core Laboratories offers well diagnostics, completion-related services, and technologies designed to support production and improve recovery.
Featured Stories
- Five stocks we like better than Core Laboratories
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
